Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mazhar Rasul

Pain Medicine Lexington, KY Medical Doctor

NPI 1790893683 CMS profile 499967

204 Somersly Pl, Lexington, KY 40515

Open in the dashboard

General payments

$29,681

126 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mazhar Rasul of Lexington, KY is reported in the CMS Open Payments database as having received $29,681 across 126 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,494 71
2024 General $5,870 49
2023 General $182 3
2020 General $35 2
2019 General $100 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mazhar Rasul
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Mazhar Rasul were reported at $23,494. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Mazhar Rasul Pain Medicine median Middle half National median
2019 $100 $506 $144–$1,566 $163
2020 $35 $315 $96–$934 $114
2021 $0 $452 $134–$1,237 $132
2022 $0 $475 $124–$1,407 $149
2023 $182 $480 $136–$1,384 $160
2024 $5,870 $521 $164–$1,511 $164
2025 $23,494 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Spinal Simplicity, LLC $22,157 57 payments
  2. MML US, Inc. $3,094 19 payments
  3. Boston Scientific Corporation $1,205 12 payments
  4. Curonix LLC $853 6 payments
  5. SI-BONE, Inc. $563 5 payments
  6. Abbott Laboratories $495 6 payments
  7. Saluda Medical Americas, Inc. $492 7 payments
  8. SPR Therapeutics, Inc $284 6 payments
  9. Medtronic, Inc. $273 5 payments
  10. Painteq LLC $166 2 payments
  11. Other $100 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $14,859 37 payments
  2. Consulting Fee $10,350 22 payments
  3. Food and Beverage $4,473 67 payments
Products named General payments · program years 2019–2025
  1. LIBERTY SI $19,208 29 payments
  2. ReActiv8 $3,094 19 payments
  3. HA MINUTEMAN G3-R $2,950 28 payments
  4. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $853 6 payments
  5. Evoke $492 7 payments
  6. IFUSE IMPLANT SYSTEM $364 3 payments
  7. ETERNA $312 3 payments
  8. SPRINT PNS System $284 6 payments
  9. INTELLIS ADAPTIVESTIM $273 5 payments
  10. General - Pain Management $227 3 payments
  11. Other $489 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$88,237

Of which drugs: $3,068

Medicare patients

57

Average age 67

Services billed

1,130

31 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Diabetes 33%
Ischemic heart disease 33%
Depression 30%
COPD 23%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 54 582 $3,066

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

126 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record